Target intelligence / Profile preview

Calcium ion homeostasis pathway

Molecular classification
Other (cellular pathways), Pathway (not a single molecular class)
01

Overview

The calcium ion homeostasis pathway is a complex network of channels, pumps, exchangers, and sensors responsible for maintaining cellular and extracellular Ca²⁺ concentrations within a precise physiological range. Major components include voltage-gated calcium channels, CRAC channels (ORAI/STIM), ryanodine receptors (RyR), inositol trisphosphate receptors (IP3R), mitochondrial calcium uniporter (MCU), and various calcium-transporting ATPases (SERCA, PMCA) and exchangers (NCX). Imbalances are associated with a wide array of diseases such as heart failure, neurodegenerative diseases, immune dysfunction, and cancer. Therapeutic targeting focuses on individual molecules within the pathway, not the pathway itself. The pathway is a conceptual network and should not be annotated as a discrete molecular target. For structured data or therapeutic development, refer to its constituent molecules (e.g., ORAI1, STIM1, voltage-gated calcium channel subtypes, CALHM family, etc.).

Other names
Calcium homeostasis pathwayCalcium signaling pathwayCalcium regulation pathwayCalcium handling pathway
02

Mechanism of action

Inhibition or activation of calcium channels (blockers, agonists); Inhibition of calcium release from intracellular stores; Inhibition of calcium-dependent enzymes (e.g., calcineurin inhibitors)

03

Biological functions

Signal transductionApoptosisCell deathCell proliferationCellular metabolismMuscle contractionImmune responseNeurotransmitter release
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInfectionImmune dysfunctionMetabolic diseaseMuscular disorders
05

Safety considerations

Disruption of calcium homeostasis can result in arrhythmia, cardiac contractility defects, muscle spasms, neurotoxicity, cell death, immune suppression
06

Interacting drugs

Calcium channel blockers (nifedipine, verapamil, diltiazem, amlodipine)

5 more in the full profile.

07

Biomarkers

Intracellular Ca²⁺ concentrationExpression levels/activity of pathway components (ORAI1, STIM1, SERCA, RyR, IP3R, CALHM family)Upregulated or mutant channel levels in certain diseases

Beyond the preview

Go deeper on Calcium ion homeostasis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium ion homeostasis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call